(1.31%) 5 130.42 points
(1.37%) 38 749 points
(2.09%) 16 171 points
(-0.22%) $78.78
(0.49%) $2.05
(-0.68%) $2 294.00
(-1.04%) $26.55
(0.42%) $966.60
(-0.47%) $0.928
(-1.37%) $10.84
(-0.34%) $0.795
(2.16%) $93.10
-0.04% $ 71.24
Live Chart Being Loaded With Signals
Prestige Consumer Healthcare Inc., together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally...
Stats | |
---|---|
Dzisiejszy wolumen | 4 579.00 |
Średni wolumen | 237 303 |
Kapitalizacja rynkowa | 3.54B |
EPS | $0 ( 2024-05-02 ) |
Last Dividend | $0.475 ( 2018-09-27 ) |
Next Dividend | $0 ( N/A ) |
P/E | -43.17 |
ATR14 | $0.0630 (0.09%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-03-01 | Fritz Mary Beth | Buy | 110 | Common Stock, par value $0.01 per share |
2024-03-01 | Fritz Mary Beth | Buy | 62 | Common Stock, par value $0.01 per share |
2024-03-01 | Fritz Mary Beth | Sell | 62 | Common Stock, par value $0.01 per share |
2024-03-01 | Fritz Mary Beth | Sell | 110 | Common Stock, par value $0.01 per share |
2024-03-01 | Fritz Mary Beth | Sell | 62 | Employee Stock Options (right to buy) |
INSIDER POWER |
---|
-21.30 |
Last 99 transactions |
Buy: 327 711 | Sell: 471 882 |
Wolumen Korelacja
Prestige Consumer Korelacja
10 Najbardziej pozytywne korelacje |
---|
10 Najbardziej negatywne korelacje |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Prestige Consumer Korelacja - Waluta/Towar
Prestige Consumer Finanse
Annual | 2023 |
Przychody: | $1.13B |
Zysk brutto: | $625.29M (55.45 %) |
EPS: | $-1.650 |
FY | 2023 |
Przychody: | $1.13B |
Zysk brutto: | $625.29M (55.45 %) |
EPS: | $-1.650 |
FY | 2022 |
Przychody: | $1.09B |
Zysk brutto: | $620.65M (57.11 %) |
EPS: | $4.09 |
FY | 2021 |
Przychody: | $943.37M |
Zysk brutto: | $547.47M (58.03 %) |
EPS: | $3.28 |
Financial Reports:
No articles found.
Prestige Consumer Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
First Dividend | $0.475 | 2018-09-27 |
Last Dividend | $0.475 | 2018-09-27 |
Next Dividend | $0 | N/A |
Payout Date | 2018-10-15 | |
Next Payout Date | N/A | |
# dividends | 1 | -- |
Total Paid Out | $0.475 | -- |
Avg. Dividend % Per Year | 0.00% | -- |
Score | 1.21 | -- |
Div. Sustainability Score | 6.61 | |
Div.Growth Potential Score | 1.405 | |
Div. Directional Score | 4.01 | -- |
Year | Amount | Yield |
---|---|---|
2018 | $0.475 | 1.08% |
2019 | $0 | 0.00% |
2020 | $0 | 0.00% |
2021 | $0 | 0.00% |
2022 | $0 | 0.00% |
2023 | $0 | 0.00% |
2024 | $0 | 0.00% |
With a moderate Dividend Sustainability Score (DSS), the company may sustain its dividends, but continuous monitoring is advised for any financial shifts. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
LOMA | Dividend Knight | 2023-06-30 | Quarterly | 2 | 5.23% | 8.53 |
PVL | Dividend King | 2023-11-15 | Monthly | 14 | 9.37% | 8.50 |
KIO | Dividend Royal | 2023-12-14 | Monthly | 12 | 7.05% | 8.50 |
NCV | Dividend Royal | 2024-02-09 | Monthly | 22 | 7.68% | 8.50 |
MTR | Dividend Diamond | 2023-10-30 | Monthly | 39 | 10.10% | 8.50 |
SBR | Dividend Royal | 2023-11-14 | Monthly | 38 | 7.74% | 8.50 |
SCM | Dividend King | 2023-12-15 | Monthly | 13 | 7.08% | 8.50 |
SJT | Dividend Royal | 2023-11-29 | Monthly | 39 | 12.52% | 8.50 |
PDI | Dividend Royal | 2023-11-10 | Monthly | 13 | 7.86% | 8.50 |
GOF | Dividend Royal | 2023-11-14 | Monthly | 18 | 8.03% | 8.50 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | -0.0711 | 1.500 | -1.422 | -2.13 | [0 - 0.5] |
returnOnAssetsTTM | -0.0242 | 1.200 | -0.805 | -0.966 | [0 - 0.3] |
returnOnEquityTTM | -0.0532 | 1.500 | -1.702 | -2.55 | [0.1 - 1] |
payoutRatioTTM | 0 | -1.000 | 0 | 0 | [0 - 1] |
currentRatioTTM | 3.09 | 0.800 | 10.00 | 8.00 | [1 - 3] |
quickRatioTTM | 1.867 | 0.800 | 3.72 | 2.98 | [0.8 - 2.5] |
cashRatioTTM | 0.499 | 1.500 | 8.34 | 10.00 | [0.2 - 2] |
debtRatioTTM | 0.363 | -1.500 | 3.94 | -5.92 | [0 - 0.6] |
interestCoverageTTM | 4.94 | 1.000 | 9.28 | 9.28 | [3 - 30] |
operatingCashFlowPerShareTTM | 4.85 | 2.00 | 8.38 | 10.00 | [0 - 30] |
freeCashFlowPerShareTTM | 4.67 | 2.00 | 7.67 | 10.00 | [0 - 20] |
debtEquityRatioTTM | 0.758 | -1.500 | 6.97 | -10.00 | [0 - 2.5] |
grossProfitMarginTTM | 0.552 | 1.000 | 4.13 | 4.13 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.309 | 1.000 | 5.83 | 5.83 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 0.199 | 1.000 | -0.00777 | -0.00777 | [0.2 - 2] |
assetTurnoverTTM | 0.340 | 0.800 | -1.069 | -0.855 | [0.5 - 2] |
Total Score | 6.61 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | -43.94 | 1.000 | -4.54 | 0 | [1 - 100] |
returnOnEquityTTM | -0.0532 | 2.50 | -1.094 | -2.55 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 4.67 | 2.00 | 8.44 | 10.00 | [0 - 30] |
dividendYielPercentageTTM | 0 | 1.500 | 0 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 4.85 | 2.00 | 8.38 | 10.00 | [0 - 30] |
payoutRatioTTM | 0 | 1.500 | 0 | 0 | [0 - 1] |
pegRatioTTM | -0.0866 | 1.500 | -3.91 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.212 | 1.000 | 7.19 | 0 | [0.1 - 0.5] |
Total Score | 1.405 |
Prestige Consumer
Prestige Consumer Healthcare Inc., together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare. It offers BC/Goody's analgesic powders, Boudreaux's Butt Paste baby ointments, Chloraseptic sore throat liquids and lozenges, Clear Eyes for eye redness relief, Compound W wart removals, DenTek for PEG oral care, Debrox ear wax removals, and Dramamine for motion sickness relief. The company also provides Fleet adult enemas/suppositories, Gaviscon upset stomach remedies, Luden's cough drops, Monistat vaginal anti-fungal, Nix lice/parasite treatments, Summer's Eve feminine hygiene, TheraTears dry eye relief, Fess nasal saline spray and washes, and Hydralyte for oral rehydration products. It sells its products through mass merchandisers; and drug, food, dollar, convenience, and club stores, as well as e-commerce channels. The company was formerly known as Prestige Brands Holdings, Inc. and changed its name to Prestige Consumer Healthcare Inc. in August 2018. Prestige Consumer Healthcare Inc. was founded in 1996 and is headquartered in Tarrytown, New York.
O Sygnały na żywo
Prezentowane na tej stronie sygnały na żywo pomagają określić, kiedy KUPIĆ lub SPRZEDAĆ BRAK DANYCH. Sygnały mogą mieć opóźnienie wynoszące nawet 1 minutę; jak wszystkie sygnały rynkowe, istnieje ryzyko błędu lub pomyłki.
Sygnały transakcyjne na żywo nie są ostateczne i getagraph.com nie ponosi odpowiedzialności za żadne działania podjęte na podstawie tych sygnałów, jak opisano w Warunkach Użytkowania. Sygnały opierają się na szerokim zakresie wskaźników analizy technicznej